Skip to main content
Log in

FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction

  • Case Report
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Chronic expanding hematoma is a rare presentation of a hematoma characterized by a persistent increase in size for more than a month after the initial hemorrhage. We present a 65-year-old man with a chronic expanding hematoma in his ilium who was receiving anticoagulant treatment. The patient had a delayed manifestation of a femoral neuropathy with massive bone destruction. 2-Deoxy-[18F]fluoro-d-glucose (FDG) positron emission tomography (PET) imaging revealed an increased uptake in the rim of the mass in images acquired 1 h after FDG injection. FDG-PET scans were performed using a dedicated PET scanner (HeadtomeV/SET2400 W, Shimadzu, Kyoto, Japan), and the PET data for the most metabolically active region of interest (ROI) were analyzed. The maximum standardized uptake value (SUVmax) was set to a cut-off point of 3.0 to distinguish between benign and malignant lesions. The SUVmax of the patient’s lesion was 3.10, suggesting a malignant lesion. The characteristics of FDG-PET images of chronic expanding hematomas, including the uptake of FDG in the peripheral rim of the mass as a result of inflammation, should be recognized as a potential interpretive pitfall in mimicking a sarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1 A
Fig. 2 A
Fig. 3 A
Fig. 4

Similar content being viewed by others

References

  1. Reid JD, Kommareddi S. Chronic expanding hematomas: a clinico-pathologic entity. JAMA 1980; 244:2441–2442.

    Article  PubMed  CAS  Google Scholar 

  2. Lewis VL Jr, Johnson PE. Chronic expanding hematoma. Plast Reconstr Surg 1987; 79:465–467.

    Article  PubMed  Google Scholar 

  3. Aoki T, Nakata H, et al. The radiological findings in chronic expanding hematoma. Skeletal Radiol 1999; 28:396–401.

    Article  PubMed  CAS  Google Scholar 

  4. Lodge MA, Lucas JD, Marsden PK, et al. A PET study of18FDG uptake in soft tissue masses. Eur J Nucl Med 1999; 26:22–30.

    Article  PubMed  CAS  Google Scholar 

  5. Schulte M, Brecht-Krauss D, Heymer B, et al. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med 1999; 26:599–605.

    Article  PubMed  CAS  Google Scholar 

  6. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32:623–648.

    PubMed  CAS  Google Scholar 

  7. Feldman F, van Heertum R, Manos C.18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol 2003; 32:201–208.

    Article  PubMed  Google Scholar 

  8. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219:774–777.

    PubMed  CAS  Google Scholar 

  9. Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol 2003; 32:133–138.

    Article  PubMed  CAS  Google Scholar 

  10. Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695–1701.

    PubMed  CAS  Google Scholar 

  11. Beckers C, Ribbens C, Andre B, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004; 45:956-964.

    PubMed  CAS  Google Scholar 

  12. Gihlmann A, Brechy-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998; 206:749–754.

    PubMed  Google Scholar 

  13. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972–1980.

    PubMed  CAS  Google Scholar 

  14. Imaizumi S, Morita T, Ogose A, et al. Soft tissue sarcoma mimicking chronic hematoma: value of magnetic resonance imaging in differential diagnosis. J Orthop Sci 2002; 7:33–37.

    Article  PubMed  Google Scholar 

  15. Sreenivas M, Nihal A, Ettles DF. Chronic haematoma or soft-tissue neoplasm? A diagnostic dilemma. Arch Orthop Trauma Surg 2004; 124:495–497.

    Article  PubMed  CAS  Google Scholar 

  16. Bush CH. The magnetic resonance imaging of musculoskeletal hemorrhage. Skeletal Radiol 2000; 29:1–9.

    Article  PubMed  CAS  Google Scholar 

  17. Kelm J, Ahlhelm F, Engel C, et al. Synovial sarcoma diagnosed after a sports injury. Am J Sports Med 2001; 29:367–369.

    PubMed  CAS  Google Scholar 

  18. Dethy S, Goldman S, Blecic S, et al. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 1994; 35:1162–1166.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Mr. Y. Nakamura and the staff of the Department of Nuclear Medicine and the Cyclotron staff of Osaka University Medical School Hospital for their technical support in performing the studies, as well as Ms. M. Sudo and K. Tsunoda for their administrative assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenichiro Hamada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamada, K., Myoui, A., Ueda, T. et al. FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction. Skeletal Radiol 34, 807–811 (2005). https://doi.org/10.1007/s00256-005-0895-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-005-0895-x

Keywords

Navigation